(1)
THE STATUS OF ADHERENCE IN LAMIVUDIN, TENOFOVIR AND DOLUTEGRAVIR USAGE TO TREAT HIV PATIENTS. YHCĐ 2022, 63 (Số tiếng Anh). https://doi.org/10.52163/yhc.v63i9.557.